Back to search
FDAFDA · Food and drugs·Recall number D-0102-2018

Pravastatin Sodium Tablets, USP, 40 mg, 30-count bottle, Rx only, Packaged for: International Laboratories, LLC. St. Petersburg, FL 33710, NDC 54458-925-16

Published December 13, 2017 · Recall initiated: August 7, 2017

Summary

FDA records drug Class I recall D-0102-2018, published December 13, 2017 and initiated August 7, 2017. Recalling firm: International Laboratories, Inc.; Status: Terminated; Reported quantity: 82056 bottles; Lot: Lot # 115698A, Exp 02/19. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Label mix-up, the product labeled as Pravastatin sodium tablets 40 mg was filled with Bupropion hydrochloride XL Tablets 300 mg.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
International Laboratories, Inc.
Distributor
U.S.A. nationwide and Puerto Rico
Lot
Lot # 115698A, Exp 02/19
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Pravastatin Sodium Tablets, USP, 40 mg, 30-count bottle, Rx only, Packaged for: International Laboratories, LLC. St. Petersburg, FL 33710, NDC 54458-925-16 recalled?

Yes. FDA published recall D-0102-2018 on December 13, 2017. Reported hazard: Labeling: Label mix-up, the product labeled as Pravastatin sodium tablets 40 mg was filled with Bupropion hydrochloride XL Tablets 300 mg.

What should I do if I have this product?

Voluntary: Firm initiated · Letter